BERNS PAUL L
CIK 1202769
Transactions on file
12
Open-market buys
4
Win rate (buys)
33%
3 scored
Avg % since filing (buys)
-1.0%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-11-05 | 2026-11-04 | LYEL Lyell Immunopharma, Inc. | 10% | Buy | 2,321,262 | $25.00M | +26.1% | open → |
| 2026-11-03 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Buy | 1,200,000 | $18.00M | -17.4% | open → | |
| 2026-06-24 | 2026-06-22 | KARD Kardigan, Inc. | Director10% | Buy | 1,250,000 | $20.00M | -11.7% | open → |
| 2026-06-22 | 2026-06-17 | KARD Kardigan, Inc. | Grant | 20,706 | $0.00 | — | open → | |
| 2026-06-22 | 2026-06-17 | KARD Kardigan, Inc. | C | 13,792,035 | $0.00 | — | open → | |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | Director | C | 7,523,682 | — | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | Director | Buy | 789,998 | $14.22M | — | open → |
| 2025-02-20 | 2025-02-18 | NMRA Neumora Therapeutics, Inc. | OfficerDirector See Remarks | Sale | 13,871 | $23.4K | -56.8% | open → |
| 2025-11-13 | 2025-11-13 | MTSR Metsera, Inc. | Disp. | 957,559 | $0.00 | — | open → | |
| 2025-11-13 | 2025-11-13 | MTSR Metsera, Inc. | Disp. | 8,313,680 | $0.00 | — | open → | |
| 2025-11-13 | 2025-11-13 | MTSR Metsera, Inc. | Disp. | 7,523,682 | $0.00 | — | open → | |
| 2025-11-13 | 2025-11-13 | MTSR Metsera, Inc. | Disp. | 4,031 | $0.00 | — | open → |